glp 1 patients NimbleRx I How to Talk to Your Doctor About Starting GLP-1 Therapy GLP-1 Survey: 37.5% of People

Multiple anti-obesity drugs and interventions are available, including for long-term use, and are proven to help sustain weight loss better than lifestyle changes alone

Returns & Exchanges: You must contact us within 14 days of receiving your order by emailing [email protected] and requesting an RMA (Return Merchandise Authorization) Number

6 Change from average baseline eGFR of 45 mL/min/1.73 m 2 : -0.35 mL/min/1.73 m 2 2 with Victoza 1.8 mg ( P =0.36) 2 +0.37 mL/min/1.73 m 2 2 with placebo 2 No dosage adjustment recommended for patients with renal impairment 1 There is limited experience with Victoza in patients with end-stage renal disease

14 Most people can manage side effects with dose adjustments or medicines to help with nausea